1// ââ News Items âââââââââââââââââââââââââââââââââââââââââââââââââ 2// Edit this file to add or update news items shown on the home page and News page. 3// 4// Fields: 5// tag â category label (e.g. "Research", "Award", "Funding") 6// title â headline shown on the card 7// date â display date (e.g. "June 28 2025") 8// excerpt â short summary shown when the item is expanded 9// previewImage â image path or URL for the card thumbnail (use null for the Juvion logo fallback) 10// media â content shown when expanded: { type: "video" | "image", src: "..." } 11// set to null if there is no media 12// href â link for "Read more" button; use "#" if there is no external link 13 14const NEWS_ITEMS = [ 15 { 16 tag: 'Research', 17 title: 'JUVION-001 New Data', 18 date: 'June 28 2025', 19 excerpt: 'JUVION-001, a naturally derived compound, shows new preclinical evidence of preserving age-related mobility across fly and rodent models.', 20 previewImage: null, 21 media: { type: 'video', src: '/assets/news/mobility_performance.mp4' }, 22 href: '#', 23 }, 24 { 25 tag: 'Accelerator', 26 title: 'Digital Health Accelerator', 27 date: 'Sept 12 2025', 28 excerpt: 'Juvion was selected for Tenity\'s Digital Health Accelerator, recognizing its EPFL spin-off platform developing therapeutics that preserve neuron-muscle communication and delay age-related mobility decline.', 29 previewImage: null, 30 media: null, 31 href: 'https://www.startupticker.ch/en/news/three-swiss-startups-selected-for-tenity-s-digital-health-accelerator', 32 }, 33 { 34 tag: 'Accelerator', 35 title: 'MassChallenge', 36 date: 'June 2 2025', 37 excerpt: 'Juvion joined the 2025 MassChallenge Switzerland cohort with its healthy-aging platform targeting brain-muscle communication, sarcopenia, and age-related immobility.', 38 previewImage: null, 39 media: null, 40 href: 'https://masschallenge.org/news/switzerland-2025-accelerator-cohort/', 41 }, 42 { 43 tag: 'Media', 44 title: 'Swiss Venture Lab', 45 date: 'May 12 2025', 46 excerpt: 'Venturelab featured Juvion as a Venture Leader Biotech for its AI-, neuroscience-, and robotics-driven approach to developing therapeutics for immobility and aging-related disease.', 47 previewImage: null, 48 media: null, 49 href: 'https://www.venturelab.swiss/Juvion-Health-Sciences-The-Venture-Leader-Biotech-shaping-aging-therapeutics', 50 }, 51 { 52 tag: 'Award', 53 title: 'IMD', 54 date: 'Feb 1 2025', 55 excerpt: 'Juvion was named an IMD 2025 Startup Competition winner for pioneering next-generation therapeutics to prevent mobility decline and combat sarcopenia.', 56 previewImage: null, 57 media: null, 58 href: 'https://www.imd.org/news/start-up/imd-reveals-2025-startup-competition-winners/', 59 }, 60 { 61 tag: 'Funding', 62 title: 'FIT Foundation', 63 date: 'Jan 15 2025', 64 excerpt: 'Juvion secured a CHF 100,000 FIT Tech Seed loan to scale its AI-, machine learning-, and robotics-enabled in vivo discovery platform for healthy aging therapeutics.', 65 previewImage: null, 66 media: null, 67 href: 'https://www.fondation-fit.ch/en/general/news/2025/two-new-fit-loans-for-juvion-health-sciences-and-neuria', 68 }, 69 { 70 tag: 'Accelerator', 71 title: 'GENILEM', 72 date: 'Jan 5 2025', 73 excerpt: 'Juvion joined GENILEM\'s three-year acceleration program, highlighting its EPFL spin-off platform and preventive solutions aimed at reducing age-related mobility loss.', 74 previewImage: null, 75 media: null, 76 href: 'https://blog.genilem.ch/docadom-hireup-juvion-life-sciences-et-moussse-accelerees-par-genilem/', 77 }, 78];
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.